<ul>
<li>Corbus Pharmaceuticals named Nishant Saxena as its first chief business officer as it moves toward registrational-stage development for its lead programs.     *      Saxena was most recently chief financial officer at Jeune Aesthetics, a unit of Krystal Biotech.     *      He previously spent more than 15 years at Evercore, most recently as a managing director in the healthcare group advising on mergers, acquisitions, financings, and partnerships. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here</li>
</ul>

CRBP

KRYS

<p>Corbus Pharmaceuticals has appointed Nishant Saxena as its first chief business officer, advancing towards registrational-stage development for its lead programs. Saxena previously served as CFO at Jeune Aesthetics and has over 15 years of experience at Evercore, focusing on healthcare mergers and acquisitions.</p>

PUBT

Corbus Pharma

Krystal Biotech

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

Invesco Nasdaq Biotechnology ETF

Direxion S&P Biotech Bull 3X

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

iShares Global Healthcare

VanEck Biotech ETF

VG Health

ALPS Medical Breakthrough

iShares US Pharma

Ark Genomic Revolution ETF

iShares Biotechnology ETF

Evercore

Corbus Pharma names Nishant Saxena chief business officer